INS and Diamond-Blackfan anemia: Therefore insulin pathway inhibition may provide an additional layer of regulation underlying the cytopenia phenotypes, and suggests a putative mechanism of the growth defect phenotypes that are both present in DBA and common to other ribosomopathies.